Division of Health and Clinical Data Biobank-Construction and Utilization biobank for genomic medicine Realization(Genome/Omics Data Production for Next Generation Medical Infrastructure)

Genomic and omics information analyzed by biological samples, which associated with health and medical information in various domestic biobanks and cohort studies, is hoped to achieve efficient and effective methods for genome medicine. There are respectively various targets of bias and technical methods on genome-omics analysis and some informatic processes for those analytic data. As it take much time and a huge cost to carry out these considerably, this program aims to produce good data strategically and efficiently using high-quality samples based on scientific merits.
By stratifying patients based on genomic data and related omics data, it is expected that results will lead to improved quality of life for patients, such as early diagnosis, early treatment, and reduction of treatment-induced side effects. The research approach established through this program can be applied to other multifactorial diseases, and it is hoped that it will contribute to research aimed at elucidating the pathology of various multifactorial diseases and implementing genomic medicine.

PS(Program Supervisor)

• NAKAGAWA Hidewaki, M.D., Ph.D., Team Leader, RIKEN Center for Integrative Medical Sciences

PO(Program Officer)

• KAWAMURA Yuki, Ph.D., Section Chief, Clinical Research Advancement Section, Research Institute, National Center for Global Health and Medicine
• MINAMINO Tohru, M.D., Ph.D., Professor and Chairman, The Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine